RenovoRx, Inc.
RNXT
$0.9403
$0.04695.25%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.90M | -2.42M | -2.88M | -2.47M | -2.39M |
| Total Depreciation and Amortization | 1.00K | 1.00K | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 715.00K | -274.00K | 590.00K | 22.00K | -264.00K |
| Change in Net Operating Assets | -123.00K | -688.00K | -142.00K | 255.00K | 356.00K |
| Cash from Operations | -2.30M | -3.38M | -2.43M | -2.19M | -2.30M |
| Capital Expenditure | 0.00 | -2.00K | -12.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -2.00K | -12.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 34.00K | 10.81M | 33.00K | 15.00K | 9.65M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 34.00K | 10.81M | 33.00K | 15.00K | 9.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.27M | 7.43M | -2.41M | -2.18M | 7.35M |